Drug Discovery Biology, Idorsia Pharmaceuticals Ltd., Allschwil, Switzerland.
University of Vienna, Faculty of Chemistry, Department of Biophysical Chemistry, Vienna, Austria.
PLoS One. 2018 Jun 27;13(6):e0199639. doi: 10.1371/journal.pone.0199639. eCollection 2018.
The use of the tellurium-centered Anderson-Evans polyoxotungstate [TeW6O24]6- (TEW) as a crystallization additive has been described. Here, we present the use of TEW as an additive in the crystallization screening of the nucleotide binding domain (NBD) of HSP70. Crystallization screening of the HSP70 NBD in the absence of TEW using a standard commercial screen resulted in a single crystal form. An identical crystallization screen of the HSP70 NBD in the presence of TEW resulted in both the "TEW free" crystal form and an additional crystal form with a different crystal packing. TEW binding was observed in both crystal forms, either as a well-defined molecule or in overlapping alternate positions suggesting translational disorder. The structures were solved by both molecular replacement and single wavelength anomalous diffraction (SAD) using the anomalous signal of a single bound molecule of TEW. This study adds one more example of TEW binding to a protein and influencing its crystallization behavior.
已经有人描述过使用碲为中心的安德森-埃文斯多钨酸盐 [TeW6O24]6- (TEW) 作为结晶添加剂。在这里,我们介绍了 TEW 在 HSP70 的核苷酸结合域 (NBD) 的结晶筛选中的应用。在没有 TEW 的情况下使用标准商业屏幕对 HSP70 NBD 进行结晶筛选,仅得到一种单晶形式。在存在 TEW 的情况下对 HSP70 NBD 进行相同的结晶筛选,得到了“无 TEW”的晶体形式和另一种具有不同晶体堆积的晶体形式。在两种晶体形式中都观察到了 TEW 结合,要么是一个明确定义的分子,要么是在重叠的替代位置,表明存在平移无序。使用 TEW 的一个结合分子的异常信号,通过分子置换和单波长异常衍射 (SAD) 两种方法解决了结构。这项研究为 TEW 结合到蛋白质并影响其结晶行为增加了另一个例子。